Blood pressure measurement in research

Gianfranco Parati, Peter De Leeuw, Miklos Illyes, Stevo Julius, Iwao Kuwajima, Jean Michel Mallion, Kuniaki Ohtsuka, Yutaka Imai

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: The aim of this paper is to summarize the issues raised during a consensus conference on the role of different blood pressure (BP) monitoring techniques in research, including pathophysiological studies, clinical outcome trials and clinical pharmacology trials. Methods: This review includes the contribution of the participants in a task force at the Eighth Consensus Conference on Ambulatory BP Monitoring (October 28-31, 2001, Sendai, Japan) and the results of a discussion open to all conference participants. Individual contributions have been summarized together with the points raised during the subsequent discussion, and the main statements are also presented in a table format. Points of consensus: (1) BP monitoring in pathophysiological studies. The essential role played by continuous BP monitoring in this field had been acknowledged, and further development of non-invasive beat-by-beat monitoring techniques has been advocated. (2) BP monitoring in clinical trials. In clinical trials automated ambulatory BP monitoring (ABPM) and self BP measurements (SBPM) at home share similar advantages, with specific features that make these approaches not alternative solutions but rather approaches able to complement each other. A few examples of application of ABPM and SBPM in clinical trials include the Treatment of Hypertension according to Home or Office Blood Pressure (THOP) trial and the Trial of Preventing Hypertension (TROPHY). (3) Use of ABPM in clinical pharmacology studies. Use of ABPM is nowan established routine, aimed at describing the 24-h effect of new antihypertensive drugs. An example of these applications that was discussed in the conference is the use of ABPM in the evaluation of a new long-acting calcium channel blocker (Barnidipine) (J-MUBA study). (4) Specific models for the analysis of BP fluctuations. The features characterizing the chronobiological approach to description of 24-h BP profiles and its limitations (mainly consisting of the high risk of data over-modelling) are discussed. Also the possible occurrence of a circaseptan (approximately with a 7-day period) rhythm in BP has been addressed, although repeated performance of 24-h ABPM over a week obviously faces a number of practical problems. (5) Progress in technology: BP monitoring and telemedicine. The possibility to implement an interactive telemonitoring system of home SBPM values and the perspectives for a clinical application of this technology in the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) trial is discussed.

Original languageEnglish
Pages (from-to)83-87
Number of pages5
JournalBlood Pressure Monitoring
Volume7
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Blood Pressure
Ambulatory Monitoring
Research
Clinical Trials
Ambulatory Blood Pressure Monitoring
Clinical Pharmacology
Hypertension
Technology
Telemedicine
Calcium Channel Blockers
Advisory Committees
Antihypertensive Agents
Japan
Research Design
Outcome Assessment (Health Care)
Equipment and Supplies

Keywords

  • Ambulatory blood pressure monitoring
  • Blood pressure variability
  • Chronobiology
  • Clinical trials
  • Home blood pressure
  • Spectral analysis
  • Telemedicine

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Parati, G., De Leeuw, P., Illyes, M., Julius, S., Kuwajima, I., Mallion, J. M., ... Imai, Y. (2002). Blood pressure measurement in research. Blood Pressure Monitoring, 7(1), 83-87. https://doi.org/10.1097/00126097-200202000-00017

Blood pressure measurement in research. / Parati, Gianfranco; De Leeuw, Peter; Illyes, Miklos; Julius, Stevo; Kuwajima, Iwao; Mallion, Jean Michel; Ohtsuka, Kuniaki; Imai, Yutaka.

In: Blood Pressure Monitoring, Vol. 7, No. 1, 2002, p. 83-87.

Research output: Contribution to journalArticle

Parati, G, De Leeuw, P, Illyes, M, Julius, S, Kuwajima, I, Mallion, JM, Ohtsuka, K & Imai, Y 2002, 'Blood pressure measurement in research', Blood Pressure Monitoring, vol. 7, no. 1, pp. 83-87. https://doi.org/10.1097/00126097-200202000-00017
Parati G, De Leeuw P, Illyes M, Julius S, Kuwajima I, Mallion JM et al. Blood pressure measurement in research. Blood Pressure Monitoring. 2002;7(1):83-87. https://doi.org/10.1097/00126097-200202000-00017
Parati, Gianfranco ; De Leeuw, Peter ; Illyes, Miklos ; Julius, Stevo ; Kuwajima, Iwao ; Mallion, Jean Michel ; Ohtsuka, Kuniaki ; Imai, Yutaka. / Blood pressure measurement in research. In: Blood Pressure Monitoring. 2002 ; Vol. 7, No. 1. pp. 83-87.
@article{104aafdedd4a42a0a6b6228057441804,
title = "Blood pressure measurement in research",
abstract = "Objective: The aim of this paper is to summarize the issues raised during a consensus conference on the role of different blood pressure (BP) monitoring techniques in research, including pathophysiological studies, clinical outcome trials and clinical pharmacology trials. Methods: This review includes the contribution of the participants in a task force at the Eighth Consensus Conference on Ambulatory BP Monitoring (October 28-31, 2001, Sendai, Japan) and the results of a discussion open to all conference participants. Individual contributions have been summarized together with the points raised during the subsequent discussion, and the main statements are also presented in a table format. Points of consensus: (1) BP monitoring in pathophysiological studies. The essential role played by continuous BP monitoring in this field had been acknowledged, and further development of non-invasive beat-by-beat monitoring techniques has been advocated. (2) BP monitoring in clinical trials. In clinical trials automated ambulatory BP monitoring (ABPM) and self BP measurements (SBPM) at home share similar advantages, with specific features that make these approaches not alternative solutions but rather approaches able to complement each other. A few examples of application of ABPM and SBPM in clinical trials include the Treatment of Hypertension according to Home or Office Blood Pressure (THOP) trial and the Trial of Preventing Hypertension (TROPHY). (3) Use of ABPM in clinical pharmacology studies. Use of ABPM is nowan established routine, aimed at describing the 24-h effect of new antihypertensive drugs. An example of these applications that was discussed in the conference is the use of ABPM in the evaluation of a new long-acting calcium channel blocker (Barnidipine) (J-MUBA study). (4) Specific models for the analysis of BP fluctuations. The features characterizing the chronobiological approach to description of 24-h BP profiles and its limitations (mainly consisting of the high risk of data over-modelling) are discussed. Also the possible occurrence of a circaseptan (approximately with a 7-day period) rhythm in BP has been addressed, although repeated performance of 24-h ABPM over a week obviously faces a number of practical problems. (5) Progress in technology: BP monitoring and telemedicine. The possibility to implement an interactive telemonitoring system of home SBPM values and the perspectives for a clinical application of this technology in the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) trial is discussed.",
keywords = "Ambulatory blood pressure monitoring, Blood pressure variability, Chronobiology, Clinical trials, Home blood pressure, Spectral analysis, Telemedicine",
author = "Gianfranco Parati and {De Leeuw}, Peter and Miklos Illyes and Stevo Julius and Iwao Kuwajima and Mallion, {Jean Michel} and Kuniaki Ohtsuka and Yutaka Imai",
year = "2002",
doi = "10.1097/00126097-200202000-00017",
language = "English",
volume = "7",
pages = "83--87",
journal = "Blood Pressure Monitoring",
issn = "1359-5237",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Blood pressure measurement in research

AU - Parati, Gianfranco

AU - De Leeuw, Peter

AU - Illyes, Miklos

AU - Julius, Stevo

AU - Kuwajima, Iwao

AU - Mallion, Jean Michel

AU - Ohtsuka, Kuniaki

AU - Imai, Yutaka

PY - 2002

Y1 - 2002

N2 - Objective: The aim of this paper is to summarize the issues raised during a consensus conference on the role of different blood pressure (BP) monitoring techniques in research, including pathophysiological studies, clinical outcome trials and clinical pharmacology trials. Methods: This review includes the contribution of the participants in a task force at the Eighth Consensus Conference on Ambulatory BP Monitoring (October 28-31, 2001, Sendai, Japan) and the results of a discussion open to all conference participants. Individual contributions have been summarized together with the points raised during the subsequent discussion, and the main statements are also presented in a table format. Points of consensus: (1) BP monitoring in pathophysiological studies. The essential role played by continuous BP monitoring in this field had been acknowledged, and further development of non-invasive beat-by-beat monitoring techniques has been advocated. (2) BP monitoring in clinical trials. In clinical trials automated ambulatory BP monitoring (ABPM) and self BP measurements (SBPM) at home share similar advantages, with specific features that make these approaches not alternative solutions but rather approaches able to complement each other. A few examples of application of ABPM and SBPM in clinical trials include the Treatment of Hypertension according to Home or Office Blood Pressure (THOP) trial and the Trial of Preventing Hypertension (TROPHY). (3) Use of ABPM in clinical pharmacology studies. Use of ABPM is nowan established routine, aimed at describing the 24-h effect of new antihypertensive drugs. An example of these applications that was discussed in the conference is the use of ABPM in the evaluation of a new long-acting calcium channel blocker (Barnidipine) (J-MUBA study). (4) Specific models for the analysis of BP fluctuations. The features characterizing the chronobiological approach to description of 24-h BP profiles and its limitations (mainly consisting of the high risk of data over-modelling) are discussed. Also the possible occurrence of a circaseptan (approximately with a 7-day period) rhythm in BP has been addressed, although repeated performance of 24-h ABPM over a week obviously faces a number of practical problems. (5) Progress in technology: BP monitoring and telemedicine. The possibility to implement an interactive telemonitoring system of home SBPM values and the perspectives for a clinical application of this technology in the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) trial is discussed.

AB - Objective: The aim of this paper is to summarize the issues raised during a consensus conference on the role of different blood pressure (BP) monitoring techniques in research, including pathophysiological studies, clinical outcome trials and clinical pharmacology trials. Methods: This review includes the contribution of the participants in a task force at the Eighth Consensus Conference on Ambulatory BP Monitoring (October 28-31, 2001, Sendai, Japan) and the results of a discussion open to all conference participants. Individual contributions have been summarized together with the points raised during the subsequent discussion, and the main statements are also presented in a table format. Points of consensus: (1) BP monitoring in pathophysiological studies. The essential role played by continuous BP monitoring in this field had been acknowledged, and further development of non-invasive beat-by-beat monitoring techniques has been advocated. (2) BP monitoring in clinical trials. In clinical trials automated ambulatory BP monitoring (ABPM) and self BP measurements (SBPM) at home share similar advantages, with specific features that make these approaches not alternative solutions but rather approaches able to complement each other. A few examples of application of ABPM and SBPM in clinical trials include the Treatment of Hypertension according to Home or Office Blood Pressure (THOP) trial and the Trial of Preventing Hypertension (TROPHY). (3) Use of ABPM in clinical pharmacology studies. Use of ABPM is nowan established routine, aimed at describing the 24-h effect of new antihypertensive drugs. An example of these applications that was discussed in the conference is the use of ABPM in the evaluation of a new long-acting calcium channel blocker (Barnidipine) (J-MUBA study). (4) Specific models for the analysis of BP fluctuations. The features characterizing the chronobiological approach to description of 24-h BP profiles and its limitations (mainly consisting of the high risk of data over-modelling) are discussed. Also the possible occurrence of a circaseptan (approximately with a 7-day period) rhythm in BP has been addressed, although repeated performance of 24-h ABPM over a week obviously faces a number of practical problems. (5) Progress in technology: BP monitoring and telemedicine. The possibility to implement an interactive telemonitoring system of home SBPM values and the perspectives for a clinical application of this technology in the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) trial is discussed.

KW - Ambulatory blood pressure monitoring

KW - Blood pressure variability

KW - Chronobiology

KW - Clinical trials

KW - Home blood pressure

KW - Spectral analysis

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=0035992087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035992087&partnerID=8YFLogxK

U2 - 10.1097/00126097-200202000-00017

DO - 10.1097/00126097-200202000-00017

M3 - Article

VL - 7

SP - 83

EP - 87

JO - Blood Pressure Monitoring

JF - Blood Pressure Monitoring

SN - 1359-5237

IS - 1

ER -